Patent details

Basic Information

Publication number:

EP1729770

PCT Application Number:

PCT/US/2005/008036

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057325540

PCT Publication Number:

WO/2005/089756

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SNS-595 AND METHODS OF USING THE SAME

French Title of Invention:

SNS-595 ET METHODES D'UTILISATION DE CE DERNIER

German Title of Invention:

SNS-595 UND ANWENDUNGSVERFAHREN

SPC Number:

Dates

Filing date:

14/03/2005

Grant date:

16/12/2009

EP Publication Date:

16/12/2009

PCT Publication Date:

29/09/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2006

EP B1 Publication Date:

16/12/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/03/2019

Expiration date:

14/03/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/03/2005

 

 

Name:

Sunesis Pharmaceuticals Inc.

Address:

395 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/02/2010

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HYDE Jennifer

Address:

United States (US)

2

Name:

WALKER Duncan

Address:

United States (US)

3

Name:

ARKIN Michelle

Address:

United States (US)

4

Name:

WRIGHT Jasmine

Address:

United States (US)

Priority

Priority Number:

553578 P

Priority Date:

15/03/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/44;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/02/2018

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages